Betts Wendy J 4

What Happened
Wendy J. Betts, a director of Cardio Diagnostics Holdings, Inc. (CDIO), was granted 3,205 derivative shares on 2026-03-31. The award is reported at $1.95 per share for a total reported value of $6,250. This was an acquisition via an award (transaction code A), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-03-31
• Filing date: 2026-04-02 (filed within the standard two-business-day window for Form 4s)
• Transaction type/code: A — Grant/Award/Other acquisition (reported as a derivative)
• Amount: 3,205 shares at $1.95 per share; total reported value $6,250
• Shares owned after transaction: not specified in the provided filing excerpt
• Footnotes/plan references: none noted in the supplied data (no 10b5-1 or tax-withholding details provided)

Context
The filing reports a derivative award (commonly RSUs or similar equity grants) rather than an open-market purchase; such awards are often compensation for board service. This is an acquisition of equity by an insider (generally viewed as more informative than a routine sale), but the filing does not disclose vesting or sale details — avoid inferring motivation from the grant alone.